Understanding how antigen location and density affect immune cell development
Potent Signal 1 as a noncanonical Signal 3: antigen location, and peptide:MHCII complex density and half-life as drivers of CD4+ T cell differentiation
This study looks at how the way immune cells show certain signals affects the development of important immune cells called CD4+ T cells, which help our body fight off diseases like cancer and autoimmune disorders, with the goal of finding better treatments.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11033605 on NIH RePORTER |
What this research studies
This research investigates how the location and density of antigens presented by immune cells influence the differentiation of CD4+ T cells, which are crucial for adaptive immune responses. The study aims to explore the roles of different signals that drive T cell activation and differentiation, particularly focusing on the strength of the antigen signal and its interaction with co-stimulatory signals. By examining these mechanisms, the research seeks to improve our understanding of immune responses in both cancer and autoimmune diseases, potentially leading to better therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with cancer or autoimmune diseases who may benefit from enhanced immune therapies.
Not a fit: Patients with conditions unrelated to immune response or those not eligible for immunotherapy may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapies for cancer and improved treatments for autoimmune conditions.
How similar studies have performed: Previous research has shown promising results in understanding T cell differentiation through similar mechanisms, indicating potential for success in this area.
Where this research is happening
Philadelphia, United States
- Children's Hosp of Philadelphia — Philadelphia, United States (Active)
Researchers
- Principal investigator: Eisenlohr, Laurence Crane — Children's Hosp of Philadelphia
- Study coordinator: Eisenlohr, Laurence Crane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.